Adiponectin levels in serum of women with pre-eclampsia;Taux sériques d'adiponectine chez les femmes souffrant de prééclampsie

Eastern Mediterranean Health Journal

Volumn 17, Issue 7, 2011, Pages 575-581

  Abd Alaleem, D I ^a   Attiaa, K I ^a   Khalefa, A A ^a   Ahmad, R A ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ESTRADIOL; PROGESTERONE;

ADULT; ARTERIAL PRESSURE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; EGYPT; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; PREECLAMPSIA; PREGNANT WOMAN; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY;

EID: 79960566604     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2011.17.7.575     Document Type: Article

References (52)

1. Cunningham FG et al, Hypertensive disorders in pregnancy. In: Cunningham FG et al., eds, Williams obstetrics, 22nd ed. New York, McGraw-Hill, 2005:761-808.
2. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet, 2001, 357:53-56.
3. Fuh MM et al. Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy. American Journal of Hypertension, 1995, 8:768-771.
4. Hubel CA et al. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. American Journal of Obstetrics and Gynecology, 1996, 174:975-982.
5. Laivuori H et al. Evidence of high circulating testosterone in women with prior preeclampsia. Journal of Clinical Endocrinology and Metabolism, 1998, 83:344-347.
6. Mise H et al. Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. Journal of Clinical Endocrinology and Metabolism, 1998, 83:3225-3229.
7. Williams MA et al. Pre-eclampsia disrupts the normal relationship between serum leptin concentrations and adiposity in pregnant women. Paediatric and Perinatal Epidemiology, 1999, 13:190-204.
8. Matsuda M et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. Journal of Biological Chemistry, 2002, 277:37487-37491.
9. Mazaki-Tovi S, Kanety H, Sivan E. Adiponectin and human pregnancy. Current Diabetes Reports, 2005, 5:278-281.
10. Arita Y et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications, 1999, 257:79-83.
11. Hotta K et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology, 2000, 20:1595-1599.
12. Yamauchi T et al. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. Journal of Clinical Investigation, 2001, 108:1001-1013.
13. Ouchi N et al. Obesity, adiponectin and vascular inflammatorydisease. Current Opinion in Lipidology, 2003, 14:561-566.
14. Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. Journal of Internal Medicine, 2005, 257:167-175.
15. Solomon CG, Seely EW. Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension, 2001, 37:232-239.
16. Sattar N et al. Leptin levels in pregnancy: marker for fat accumulation and mobilization? Acta Obstetricia et Gynecologica Scandinavica, 1998, 77:278-283.
17. Arita Y et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation, 2002, 105:2893-2898.
18. Matsuda M et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. Journal of Biological Chemistry, 2002, 277:37487-37491.
19. Kobayashi H et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circulation Research, 2004, 94:e27-e31.
20. Engeli S et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes, 2003, 52:942-947.
21. Ouchi N et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension, 2003, 42:231-234.
22. Shand BI et al. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes, Obesity and Metabolism, 2003, 5:349-353.
23. Tan KCB et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. Journal of Clinical Endocrinology and Metabolism, 2004, 89:765-769.
24. Fernández-Real JM et al. Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care, 2004, 27:739-745.
25. Habli M, Sibai BM. Hypertensive disorders of pregnancy. In: Gibbs RS, Karlan BY, eds. Danforth's obstetrics and gynecology, 10th ed. Philadelphia, Lippincott Williams & Wilkins, 2008:258-275.
26. McCarthy JF, Misra DN, Roberts JM. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. American Journal of Obstetrics and Gynecology, 1999, 180:731-736.
27. Dilena BA, Penberthy LA, Fraser CG. Six methods for determining urinary protein compared. Clinical Chemistry, 1983, 29:553-557.
28. Tietz NW, ed. Clinical guide to laboratory tests, 3rd ed. Philadelphia, WB Saunders, 1995:509-512.
29. Davis GK et al. Predicting transformation from gestational hypertension to preeclampsia in clinical practice: a possible role for 24 hour ambulatory blood pressure monitoring. Hypertension in Pregnancy, 2007, 26:77-87.
30. D'Anna R et al. Adiponectin and insulin resistance in early-and late-onset pre-eclampsia. British Journal of Obstetrics and Gynaecology, 2006, 113:1264-1269.
31. Ramsay JE et al. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension, 2003, 42:891-894.
32. Kajantie E et al. Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity. Journal of the Society for Gynecologic Investigation, 2005, 12:433-439.
33. Herse F et al. Circulating and uteroplacental adipocytokine concentrations in preeclampsia. Reproductive Sciences, 2009, 16:584-590.
34. Ozkan S et al. Serum leptin levels in hypertensive disorder of pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2005, 120:158-163.
35. Hendler I et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. American Journal of Obstetrics and Gynecology, 2005, 193:979-983.
36. Caminos JE et al. Expression and regulation of adiponectin and receptor in human and rat placenta. Journal of Clinical Endocrinology and Metabolism, 2005, 90:4276-4286.
37. Wolf M et al. First trimester insulin resistance and subsequent pre-eclampsia: a prospective study. Journal of Clinical Endocrinology and Metabolism, 2002, 87:1563-1568.
38. Sattar N et al. Classic and novel risk factor parameters in women with a history of pre-eclampsia. Hypertension, 2003, 42:39-42.
39. Mazaki-Tovi S, Kanety H, Sivan E. Adiponectin and human pregnancy. Current Diabetes Reports, 2005, 5:278-281.
40. Sagawa N et al. Role of leptin in pregnancy. Placenta, 2002, 23:S80.
41. Ouchi N et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation, 2000, 102:1296-1301.
42. Fasshauer M et al. Circulating high molecular weight adiponectin is upregulated in pre-eclampsia and is related to insulin sensitivity and renal function. European Journal of Endocrinology, 2008, 158:197-201.
43. Li J et al. AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circulation Research, 2005, 97:872-879.
44. Ouchi N, Shibata R, Walsh K. Targeting adiponectin for cardioprotection. Expert Opinion on Therapeutic Targets, 2006, 10:573-581.
45. Yamauchi T et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. Journal of Biological Chemistry, 2003, 278:2461-2468.
46. Davison JM et al. New aspects in the pathophysiology of preeclampsia. Journal of the American Society of Nephrology, 2004, 15:2440-2448.
47. Nien JK et al. Adiponectin in severe preeclampsia. Journal of Perinatal Medicine, 2007, 35:503-512.
48. Ichida K et al. Plasma adiponectin concentrations and placental adiponectin expression in pre-eclamptic women. Gynecological Endocrinology, 2007, 23:238-243.
49. Nakatsukasa H et al. Circulating leptin and angiogenic factors in preeclampsia patients. Endocrine Journal, 2008, 55:565-573.
50. Ouyang YQ et al. Plasma sFLt-1 to PIGF ratio is correlated with inflammatory but not with oxidative stress in Chinese preeclamptic women. Archives of Gynecology and Obstetrics, 2008, 280:91-97
51. Girouard J et al. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension, 2007, 49:1056-1062.
52. Ouyang Y, Chen H, Chen H. Reduced plasma adiponectin and elevated leptin in pre-eclampsia. International Journal of Gynaecology and Obstetrics, 2007, 98:110-114.